Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All ...

Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

SHANGHAI, China I March 23, 2025 I Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, ...

Johnson & Johnson (NYSE:JNJ) experienced an 11% price increase over the last quarter. This movement coincided with several ...

BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which ...

Approximately 80% of individuals who receive immune checkpoint inhibitors for advanced cancer do not respond to therapy, according to results of a cross-sectional analysis.The number of FDA-approved ...

A federal lawsuit filed this week charges that a Huerfano County deputy tackled a confused inmate undergoing a mental health ...

Genelux Corporation’s GNLX share price has dipped by 12.21%, which has investors questioning if this is right time to buy.

ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the "Company", "Zefiro", or "ZEFI") today announced that it has engaged TÜV SÜD America ("TÜV SÜD"), a technical inspection association that tests, inspects, ...

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce that Miriam Martin, a long-standing member of the organization, has been appointed Vice President ...